Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP177976.RA_uGcVrTdi0sKGaR7r1BcOkxhvmLWLUKRK7Fy45tb2dA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP177976.RA_uGcVrTdi0sKGaR7r1BcOkxhvmLWLUKRK7Fy45tb2dA130_assertion type Assertion NP177976.RA_uGcVrTdi0sKGaR7r1BcOkxhvmLWLUKRK7Fy45tb2dA130_head.
- NP177976.RA_uGcVrTdi0sKGaR7r1BcOkxhvmLWLUKRK7Fy45tb2dA130_assertion description "[CL-1 and CL-2 offer a unique and reproducible model for the evaluation of drug sensitivity and for other therapeutic modalities for advanced prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP177976.RA_uGcVrTdi0sKGaR7r1BcOkxhvmLWLUKRK7Fy45tb2dA130_provenance.
- NP177976.RA_uGcVrTdi0sKGaR7r1BcOkxhvmLWLUKRK7Fy45tb2dA130_assertion evidence source_evidence_literature NP177976.RA_uGcVrTdi0sKGaR7r1BcOkxhvmLWLUKRK7Fy45tb2dA130_provenance.
- NP177976.RA_uGcVrTdi0sKGaR7r1BcOkxhvmLWLUKRK7Fy45tb2dA130_assertion SIO_000772 11038142 NP177976.RA_uGcVrTdi0sKGaR7r1BcOkxhvmLWLUKRK7Fy45tb2dA130_provenance.
- NP177976.RA_uGcVrTdi0sKGaR7r1BcOkxhvmLWLUKRK7Fy45tb2dA130_assertion wasDerivedFrom befree-20140225 NP177976.RA_uGcVrTdi0sKGaR7r1BcOkxhvmLWLUKRK7Fy45tb2dA130_provenance.
- NP177976.RA_uGcVrTdi0sKGaR7r1BcOkxhvmLWLUKRK7Fy45tb2dA130_assertion wasGeneratedBy ECO_0000203 NP177976.RA_uGcVrTdi0sKGaR7r1BcOkxhvmLWLUKRK7Fy45tb2dA130_provenance.